Search

Author/Creator Terrill, Paul

1. Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert group. (26th July 2013)

Authors:
Phillips, Alan; Fletcher, Chrissie; Atkinson, Gary; Channon, Eddie; Douiri, Abdel; Jaki, Thomas; Maca, Jeff; Morgan, David; Roger, James Henry; Terrill, Paul
Journal:
Pharmaceutical statistics
Issue:
Volume 12:Number 5(2013:Sep./Oct.)
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials. Issue 12 (December 2022)

Authors:
Donnez, Jacques; Taylor, Hugh S.; Stewart, Elizabeth A.; Bradley, Linda; Marsh, Erica; Archer, David; Al-Hendy, Ayman; Petraglia, Felice; Watts, Nelson; Gotteland, Jean-Pierre; Bestel, Elke; Terrill, Paul; Loumaye, Ernest; Humberstone, Andrew; Garner, Elizabeth
Journal:
Obstetrical & gynecological survey
Issue:
Volume 77:Issue 12(2022)
Page Start:
741
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Issue 10356 (17th September 2022)

Authors:
Donnez, Jacques; Taylor, Hugh S; Stewart, Elizabeth A; Bradley, Linda; Marsh, Erica; Archer, David; Al-Hendy, Ayman; Petraglia, Felice; Watts, Nelson; Gotteland, Jean-Pierre; Bestel, Elke; Terrill, Paul; Loumaye, Ernest; Humberstone, Andrew; Garner, Elizabeth
Journal:
Lancet
Issue:
Volume 400:Issue 10356(2022)
Page Start:
896
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗